Lycium barbarum polysaccharides (LBP) suppresses hypoxia/reoxygenation (H/R)-induced rat H9C2 cardiomyocytes pyroptosis via Nrf2/HO-1 signaling pathway
Year: 2024
Type: article
Abstract: This study aimed to explore the mechanism that Lycium barbarum polysaccharides (LBP) suppress hypoxia/reoxygenation (H/R)-caused pyroptosis in cardiomyocytes (H9C2) via the Nrf2/HO-1 pathway. Initially, we established the cell model of H/R (6 h hypoxia plus with 24 h reoxygenation), and found that 90 μg/mL LBP was the optimal concentration. Subsequently, we confirmed that LBP reduced the apoptosis rate of cells after H/R, the activity of LDH, the inflammatory factors IL-1β and IL-18, and the levels of pyroptosis-specific markers ASC, NLRP3, and Caspase-1 (mRNAs and proteins). It increased the cell survival rate and the mRNA levels of the Nrf2/HO-1 pathway markers Nrf2 and HO-1, and allowed cytoplasmic Nrf2 protein to enter the nucleus to activate HO-1 protein. The Nrf2 siRNA2 caused the following events in H/R model: (1) the increases of the apoptosis rate, LDH activity, the levels of inflammatory factors (IL-1β and IL-18), the levels of ACS, NLRP3, and Caspase-1 (mRNAs and proteins); and (2) the decreases of the cell survival rate, the mRNA levels of Nrf2 and HO-1, and the protein levels of cytoplasm-Nrf2, nucleus-Nrf2, and HO-1. Therefore we concluded that 90 μg/mL LBP suppressed H/R-induced H9C2 cardiomyocyte pyroptosis via the Nrf2/HO-1 pathway. • LBP protected H9C2 against H/R-injury, and reduced the levels of pyroptosis-specific markers ASC, NLRP3 and Caspase-1. • LBP allowed cytoplasmic Nrf2 protein to enter the nucleus to activate HO-1 protein. • Nrf2 siRNA2 blocked the protection of LBP inH9C2 cells after H/R. • LBP could suppresses H/R-induced H9C2 cardiomyocytes pyroptosis via Nrf2/HO-1 signaling pathway.
Authors: Yi Gao, Huangen Li, Yongkang Que, Weiwen Chen, Shi-Ying Huang, Wenjie Liu, Xiaotong Ye
Institutions: Huaqiao University, Fujian Medical University, Jimei University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,260
Award: G849136837
OpenAlex ID: W4402738892
